Grace Therapeutics, Inc.: Form 8-K, filed Aug 6, 2026
Filed with the SEC on Aug 6, 2026 and accepted by EDGAR at Aug 6, 2026, 16:06 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-26-031671. Last ingested by Listed: Oct 26, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.